Inventor · disambiguated record
Russell Hagan
Also filed as: HAGAN RUSSELL · HAGAN RUSSELL M · HAGAN RUSSELL MICHAEL
9 granted patents·5 pending applications·95 citations·filing 1983–2012
88Inventor score
Top patents by PatentIndex Score
14 records- 0187US7342028B2Medical use for tachykinin antagonistsGLAXO GROUP LTD·Filed 2004·Granted Mar 11, 2008·19 cites·4 claims
- 0278US6191139B1Medical use for tachykinin antagonistsGLAXO GROUP LTD·Filed 1999·Granted Feb 20, 2001·27 cites·2 claims
- 0370US8609633B2Core 2 GlcNAc-T inhibitorsCHIBBER RAKESH·Filed 2011·Granted Dec 17, 2013·2 cites·25 claims
- 0469US8197794B2Core 2 GlcNAc-T inhibitorsCHIBBER RAKESH·Filed 2009·Granted Jun 12, 2012·1 cites·5 claims
- 0569US7998943B2Core 2 GlcNAc-T inhibitors IIIBTG INT LTD·Filed 2006·Granted Aug 16, 2011·1 cites·54 claims
- 0665US7214692B2Medical use for tachykinin antagonistsGLAXO GROUP LTD·Filed 2001·Granted May 8, 2007·1 cites·25 claims
- 0762US4506519AHermetic compressor discharge line thermal blockTECUMSEH PRODUCTS CO·Filed 1983·Granted Mar 26, 1985·23 cites·21 claims
- 0861US2010048496A1Core 2 GlcNAc-T inhibitorsBTG INT LTD·Filed 2009·Application pending·0 cites
- 0957US6329394B1Medical use for tachykinin antagonistsGLAXO GROUP LTD·Filed 1996·Granted Dec 11, 2001·14 cites·4 claims
- 1057US2010048495A1Core 2 GlcNAc-T inhibitors IIIBTG INT LTD·Filed 2009·Application pending·0 cites
- 1156US2008182801A1Core 2 glcnac-t inhibitorsBTG INT LTD·Filed 2007·Application pending·0 cites
- 1254US5798363AUse for tachykinin antagonists to treat emesisGLAXO GROUP LTD·Filed 1995·Granted Aug 25, 1998·7 cites·12 claims
- 1347US2012202758A1Core 2glcnac-t inhibitorsCHIBBER RAKESH·Filed 2012·Application pending·0 cites
- 1442US2007010460A1Multiple sclerosis therapy and diagnosisBTG INT LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Russell Hagan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →